Cardiac CIP protein regulates dystrophic cardiomyopathy
Cardiac CIP protein regulates dystrophic cardiomyopathy
复制标题
心脏 CIP 蛋白调节营养不良性心肌病
DOI:
10.1016/j.ymthe.2021.08.022
复制
发表时间:
2022-02-02
影响因子:
12.4
通讯作者:
Wang, Da-Zhi
中科院分区:
文献类型:
--
作者:
He, Xin;Liu, Jianming;Wang, Da-Zhi
Heart failure is a leading cause of fatality in Duchenne muscular dystrophy (DMD) patients. Previously, we discovered that cardiac and skeletal-muscle-enriched CIP proteins play important roles in cardiac function. Here, we report that CIP, a striated muscle-specific protein, participates in the regulation of dystrophic cardiomyopathy. Using a mouse model of human DMD, we found that deletion of CIP leads to dilated cardiomyopathy and heart failure in young, non-syndromic mdx mice. Conversely, transgenic overexpression of CIP reduces pathological dystrophic cardiomyopathy in old, syndromic mdx mice. Genomewide transcriptome analyses reveal that molecular pathways involving fibrogenesis and oxidative stress are affected in CIP(CnA) to suppress the CnA-Nuclear Factor of Activated T cells (NFAT) pathway, which results in decreased expression of Nox4, a key component of the oxidative stress pathway. Overexpression of Nox4 accelerates the development of dystrophic cardiomyopathy in mdx mice. Our study indicates CIP is a modifier of dystrophic cardiomyopathy and a potential therapeutic target for this devastating disease.